Deployment addresses the $1 billion antibody-reproducibility crisis by enabling rapid, objective validation of research reagents, reducing wasted time and cost in research and drug development.
Next-Generation Biologics and Biosimilars Market to Hit 251.13 billion Dollars by 2033 - Strategic Revenue Insights (SRI) ...
Automated pipette-based Protein A micro-purification is fast, accurate, and less expensive than traditional purification methods.
As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new ...
Rising adoption of automated and AI-enabled synthesis platforms positions pharmaceutical and biotechnology companies for ...
The global GMP peptides market size was valued at USD 1.3 billion in 2024 and is predicted to hit around USD 2.9 billion by ...
In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.
The custom antibody market is projected to grow at a CAGR of roughly 10% over the forecast period. This expansion is fueled ...
Persistent contacts between Climp63 and microtubules cause mitotic defects and nuclear fragmentation
This important study reveals that mitotic release of an ER-microtubule tether is critical for normal mitotic progression. Manipulating CLIMP63 phosphorylation, the authors provide convincing evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback